The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Treatments are more likely to be successful when you start them early rather than waiting to see if the symptoms get worse. Not every migraine episode has an aura. About one-quarter of people with ...

A leading cardiology doctor says this reinforces the importance of studying gender-specific health trends in research.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Millions of people around the globe are impacted by migraines every day. This neurological issue commonly results in headaches. However, its implications extend beyond discomfort. Knowledge about the ...

The most common symptoms include ... A vestibular migraine could also be confused with migraine with brain stem aura. With this rare type of migraine, attacks start in the brain stem, the lower ...

A history of migraine, with or without aura, was a significant risk factor for open-angle glaucoma onset among a cohort of ...

Pre-migraine is one of the four stages of a migraine attack. Pre-migraine symptoms may occur before a migraine attack begins. You may be able to take steps to avoid a painful migraine attack if ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

The US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the ...

Clinical trials demonstrated that a single dose of Symbravo provides rapid migraine relief, sustains efficacy for up to 48 hours, and reduces the need for rescue medication. The FDA has approved ...